Who
Kenneth Carl Anderson
Director
Company insider
Files Form 4 as: Director, C4 Therapeutics.
In numbers
- Trades disclosed
- 78
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Oct 2020
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K3,662 at $3.14 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $12K2,650 at $4.34 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $12K2,650 at $4.34 | filing |
| 24 Jun 2026filed 26 Jun 2026 | CCCC C4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,000 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | CCCC C4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,000 at $0.00 | filing |
| 1 Jun 2026filed 4 Jun 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | $2,2581,070 at $2.11 | filing |
| 1 Jun 2026filed 4 Jun 2026 | CCCC C4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,070 at $0.00 | filing |
| 1 Jun 2026filed 4 Jun 2026 | CCCC C4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,070 at $0.00 | filing |
| 1 Jun 2026filed 4 Jun 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | $2,2581,070 at $2.11 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K4,259 at $2.70 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K4,259 at $2.70 | filing |
| 2 Jan 2026filed 5 Jan 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K5,958 at $1.93 | filing |
| 2 Jan 2026filed 5 Jan 2026 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K5,958 at $1.93 | filing |
| 1 Oct 2025filed 3 Oct 2025 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $12K5,349 at $2.15 | filing |
| 1 Jul 2025filed 2 Jul 2025 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $12K7,616 at $1.51 | filing |
| 18 Jun 2025filed 20 Jun 2025 | CCCC C4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,500 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K7,841 at $1.44 | filing |
| 2 Jan 2025filed 3 Jan 2025 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K3,074 at $3.66 | filing |
| 1 Oct 2024filed 2 Oct 2024 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K2,023 at $5.56 | filing |
| 1 Jul 2024filed 2 Jul 2024 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K2,320 at $4.85 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.